Agios Pharma (AGIO)
37.18
+0.54 (1.47%)
Upcoming Events
Latest Headlines
Form 144 AGIOS PHARMACEUTICALS, Filed by: Gheuens Sarah
October 21, 2026 5:32 PM - SEC Filing
Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald as PDUFA Date Approaches
October 15, 2026 7:28 AM - StreetInsider
Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET
October 8, 2026 7:00 AM - Globe NewsWire
Agios Pharma (AGIO) PT Lowered to $37 at Truist Securities
October 7, 2026 7:13 AM - StreetInsider
TD Cowen Assumes Agios Pharma (AGIO) at Buy
August 22, 2026 7:55 AM - StreetInsider
Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
August 17, 2026 7:54 AM - StreetInsider
Agios Pharma (AGIO) PT Raised to $34 at JPMorgan
August 7, 2026 8:57 AM - StreetInsider
Form 4 AGIOS PHARMACEUTICALS, For: Aug 04 Filed by: Gheuens Sarah
August 6, 2026 4:19 PM - SEC Filing
Form 144 AGIOS PHARMACEUTICALS, Filed by: Gheuens Sarah
August 4, 2026 4:09 PM - SEC Filing
Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
August 3, 2026 8:30 AM - SEC Filing
Agios Pharma (AGIO) PT Lowered to $39 at Truist Securities
July 31, 2026 7:09 AM - StreetInsider
Form 10-Q AGIOS PHARMACEUTICALS, For: Jun 30
July 30, 2026 9:56 AM - SEC Filing
Agios Pharma (AGIO) Misses Q2 EPS by 4c
July 30, 2026 6:33 AM - StreetInsider
Form 8-K AGIOS PHARMACEUTICALS, For: Jul 30
July 30, 2026 6:33 AM - SEC Filing
Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026 6:30 AM - Globe NewsWire
Full Article List
